Author Archives: admin


Stem Cell Clinic > Articles by: admin

Aligos Therapeutics Presents Coronavirus Therapeutic Screening Assay Development at ISIRV-AVG Conference

By Global News Feed

SOUTH SAN FRANCISCO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Aligos), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that the company is presenting an e-poster at the virtual Therapeutics for COVID-19 meeting held by the International Society for Influenza and other Respiratory Virus Diseases-Antiviral Group (ISIRV-AVG), taking place October 6 – 8 from noon to 4 p.m. GMT.

Read more:
Aligos Therapeutics Presents Coronavirus Therapeutic Screening Assay Development at ISIRV-AVG Conference

FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List

By Global News Feed

HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is proud to announce Global Smart Leaders Magazine has named them the #2 Most Innovative Company of 2020. The detailed profile interview can be found here: https://globalsmartleaders.com/fibrogenesis-treatingcovid-19-and-other-chronic/

Visit link:
FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List

Stabilization measures taken

By Global News Feed

Orphazyme A/SCompany announcement                                                                                       No. 64/2020                                                                                                         Company Registration No. 32266355

More:
Stabilization measures taken

American Gene Technologies to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

By Global News Feed

ROCKVILLE, Md., Oct. 08, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) a cutting-edge cell and gene therapy company in Rockville, Maryland announced today that CEO Jeff Galvin will present at the annual Cell & Gene Meeting on the Mesa. The meeting will be held virtually October 12-16. Galvin’s presentation will highlight the company's technology, including AGT103-T, a therapeutic intended to cure HIV, which is scheduled to begin Phase 1 clinical trials this month.

Follow this link:
American Gene Technologies to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

→←